Nintedanib in Progressive Fibrosing Interstitial Lung DiseasesKevin R. Flaherty, Kevin K. Brown, Athol U. Wells et al.|New England Journal of Medicine|2019Cited by 2.3k
Withdrawal of Inhaled Glucocorticoids and Exacerbations of COPDH Magnussen, Peter M.A. Calverley, Pascal Chanez et al.|New England Journal of Medicine|2014Cited by 621
Blood eosinophil count and exacerbations in severe chronic obstructive pulmonary disease after withdrawal of inhaled corticosteroids: a post-hoc analysis of the WISDOM trialHenrik Watz, Peter M.A. Calverley, Kay Tetzlaff et al.|The Lancet Respiratory Medicine|2016Cited by 420
Tiotropium and olodaterol fixed-dose combination <i>versus</i> mono-components in COPD (GOLD 2–4)Roland Buhl, Eric Bateman, François Maltais et al.|European Respiratory Journal|2015Cited by 322
The natural history of progressive fibrosing interstitial lung diseasesKevin K. Brown, Athol U. Wells, Simon Walsh et al.|European Respiratory Journal|2020Cited by 288